Activating Cannabinoid Receptor 2 Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis Via Activation of Autophagy and Inhibiting NLRP3 Inflammasome

MLA

Bo-Zong Shao, et al. “Activating Cannabinoid Receptor 2 Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis Via Activation of Autophagy and Inhibiting NLRP3 Inflammasome.” CNS Neuroscience & Therapeutics, vol. 20, Nov. 2014, pp. 1021–28. EBSCOhost, https://doi.org/10.1111/cns.12349.

APA

Bo-Zong Shao, Wei Wei, Ping Ke, Zhe-Qi Xu, Chong Liu, & Jv-Xiang Zhou. (2014). Activating Cannabinoid Receptor 2 Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis Via Activation of Autophagy and Inhibiting NLRP3 Inflammasome. CNS Neuroscience & Therapeutics, 20, 1021–1028. https://doi.org/10.1111/cns.12349

Chicago

Bo-Zong Shao, Wei Wei, Ping Ke, Zhe-Qi Xu, Chong Liu, and Jv-Xiang Zhou. 2014. “Activating Cannabinoid Receptor 2 Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis Via Activation of Autophagy and Inhibiting NLRP3 Inflammasome.” CNS Neuroscience & Therapeutics 20 (November): 1021–28. doi:10.1111/cns.12349.